{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T16:15:10Z","timestamp":1775837710352,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.pharep.2017.10.008","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T20:17:31Z","timestamp":1519157851000},"page":"227-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia"],"prefix":"10.1007","volume":"70","author":[{"given":"Robert","family":"Krysiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Witold","family":"Szkr\u00f3bka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogus\u0142aw","family":"Okopie\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2017.10.008_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0149-7634(01)00036-7","article-title":"Orgasm-induced prolactin secretion: feedback control of sexual drive?","volume":"26","author":"Kr\u00fcger","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharep.2017.10.008_bib0010","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/humrep\/des003","article-title":"Prolactin secretory rhythm in women: immediate and long-term alterations after sexual contact","volume":"27","author":"Kruger","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.pharep.2017.10.008_bib0015","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/jsm.12097","article-title":"The quality of sexual experience in women correlates with post-orgasmic prolactin surges: results from an experimental prototype study","volume":"10","author":"Leeners","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.pharep.2017.10.008_bib0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biopsycho.2005.06.008","article-title":"The post-orgasmic prolactin increase following intercourse is greater than following masturbation and suggests greater satiety","volume":"71","author":"Brody","year":"2006","journal-title":"Biol Psychol"},{"key":"10.1016\/j.pharep.2017.10.008_bib0025","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1743-6109.2008.01206.x","article-title":"Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction","volume":"6","author":"Corona","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.pharep.2017.10.008_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.ijir.3901158","article-title":"Psycho-biological correlates of hypoactive sexual desire in patients with erectile dysfunction","volume":"16","author":"Corona","year":"2004","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.pharep.2017.10.008_bib0035","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1097\/01.ju.0000176456.50491.51","article-title":"Sexual dysfunction in women with hyperprolactinemia: a pilot study report","volume":"174","author":"Kadioglu","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.pharep.2017.10.008_bib0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s12020-016-0898-5","article-title":"Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study","volume":"53","author":"Krysiak","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.pharep.2017.10.008_bib0045","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/ENDO:28:1:101","article-title":"Treatment of pituitary tumors: dopamine agonists","volume":"28","author":"Iv\u00e1n","year":"2005","journal-title":"Endocrine"},{"key":"10.1016\/j.pharep.2017.10.008_bib0050","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1530\/eje.0.1380286","article-title":"Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine","volume":"138","author":"De Rosa","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharep.2017.10.008_bib0055","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0140-6736(77)90941-2","article-title":"Bromocriptine in impotence","volume":"2","author":"Ambrosi","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2017.10.008_bib0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1677\/joe.0.1790357","article-title":"Effects of acute prolactin manipulation on sexual drive and function in males","volume":"179","author":"Kr\u00fcger","year":"2003","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharep.2017.10.008_bib0065","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The female sexual function index (FSFI): a multidimensional selfreport instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.pharep.2017.10.008_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00926230590475206","article-title":"The female sexual function index (FSFI): cross-validation and development of clinical cut-off scores","volume":"31","author":"Wiegel","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.pharep.2017.10.008_bib0075","series-title":"BDI-II: Beck Depression Inventory Manual","author":"Beck","year":"1996"},{"key":"10.1016\/j.pharep.2017.10.008_bib0080","series-title":"Diagnostic and statistical manual of mental disorders\u2014DSM-IV-TR","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.pharep.2017.10.008_bib0085","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/oby.2010.150","article-title":"BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists","volume":"19","author":"dos Santos Silva","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.pharep.2017.10.008_bib0090","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11102-010-0277-9","article-title":"Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy","volume":"14","author":"Berinder","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/j.pharep.2017.10.008_bib0095","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s13277-013-0660-z","article-title":"BMI, apolipoprotein B\/apolipoprotein A-I ratio, and insulin resistance in patients with prolactinomas: a pilot study in a Chinese cohort","volume":"34","author":"Jiang","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.pharep.2017.10.008_bib0100","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/bcpt.12307","article-title":"Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels","volume":"116","author":"Krysiak","year":"2015","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.pharep.2017.10.008_bib0105","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03570.x","article-title":"Macroprolactinemia prevalence and aetiologies in a large group of hospital workers","volume":"71","author":"Hattori","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharep.2017.10.008_bib0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2013.07.002","article-title":"Determination of prolactin: the macroprolactin problem","volume":"27","author":"Fahie-Wilson","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.pharep.2017.10.008_bib0115","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/cen.12956","article-title":"Sexual function and depressive symptoms in young women with thyroid autoimmunity and subclinical hypothyroidism","volume":"84","author":"Krysiak","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharep.2017.10.008_bib0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bpobgyn.2007.08.002","article-title":"Hyperprolactinaemia","volume":"22","author":"Prabhakar","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.pharep.2017.10.008_bib0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-5728(00)00302-7","article-title":"Prolactin in autoimmunity and antitumor defence","volume":"109","author":"Matera","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharep.2017.10.008_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/7854_2012_211","article-title":"Inflammation and depression","volume":"14","author":"Zunszain","year":"2013","journal-title":"Curr Top Behav Neurosci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017306461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017306461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:23Z","timestamp":1752611843000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.10.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1734114017306461"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.10.008","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of bromocriptine treatment on sexual functioning and depressive symptoms in women with mild hyperprolactinemia","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}